SEER, INC. Revenue
SEER, INC. (SEER) reported Revenue of $3.10 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-11
- SEER, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $3.10M, a 23.43% decline year-over-year.
- SEER, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $2.79M, a 33.58% decline year-over-year.
- SEER, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $4.20M, a 5.02% increase year-over-year.
- SEER, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $4.12M, a 2.21% increase year-over-year.
- SEER, INC. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $16.58M, a 16.99% increase from fiscal 2024.
- SEER, INC. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $14.17M, a 14.95% decline from fiscal 2023.
- SEER, INC. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $16.66M, a 7.54% increase from fiscal 2022.
- SEER, INC. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $15.49M, a 134.14% increase from fiscal 2021.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.10M 10-Q · filed 2026-08-11 | $5.89M 10-Q · filed 2026-08-11 | $10.10M derived: sum of 3 quarters · filed 2026-08-11 | $14.22M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $2.79M 10-Q · filed 2026-05-13 | $6.99M derived: sum of 2 quarters · filed 2026-05-13 | $11.12M derived: sum of 3 quarters · filed 2026-05-13 | $15.17M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $4.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $8.32M derived: sum of 2 quarters · filed 2026-03-02 | $12.37M derived: sum of 3 quarters · filed 2026-08-11 | $16.58M 10-K · filed 2026-03-02 |
| 2025-09-30 | $4.12M 10-Q · filed 2025-11-06 | $8.17M derived: sum of 2 quarters · filed 2026-08-11 | $12.38M 10-Q · filed 2025-11-06 | $16.38M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $4.05M 10-Q · filed 2026-08-11 | $8.26M 10-Q · filed 2026-08-11 | $12.26M derived: sum of 3 quarters · filed 2026-08-11 | $16.29M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $4.21M 10-Q · filed 2026-05-13 | $8.21M derived: sum of 2 quarters · filed 2026-05-13 | $12.24M derived: sum of 3 quarters · filed 2026-05-13 | $15.31M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $8.03M derived: sum of 2 quarters · filed 2026-03-02 | $11.10M derived: sum of 3 quarters · filed 2026-03-02 | $14.17M 10-K · filed 2026-03-02 |
| 2024-09-30 | $4.03M 10-Q · filed 2025-11-06 | $7.10M derived: sum of 2 quarters · filed 2025-11-06 | $10.17M 10-Q · filed 2025-11-06 | $14.61M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $3.07M 10-Q · filed 2025-08-06 | $6.14M 10-Q · filed 2025-08-06 | $10.58M derived: sum of 3 quarters · filed 2025-08-06 | $14.74M derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | $3.07M 10-Q · filed 2025-05-13 | $7.50M derived: sum of 2 quarters · filed 2025-05-13 | $11.67M derived: sum of 3 quarters · filed 2025-05-13 | $15.67M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $4.44M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $8.60M derived: sum of 2 quarters · filed 2025-03-03 | $12.61M derived: sum of 3 quarters · filed 2025-03-03 | $16.66M 10-K · filed 2025-03-03 |
| 2023-09-30 | $4.16M 10-Q · filed 2024-11-06 | $8.17M derived: sum of 2 quarters · filed 2024-11-06 | $12.22M 10-Q · filed 2024-11-06 | $16.83M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $4.01M 10-Q · filed 2024-08-08 | $8.06M 10-Q · filed 2024-08-08 | $12.67M derived: sum of 3 quarters · filed 2024-08-08 | $16.62M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $4.05M 10-Q · filed 2024-05-08 | $8.66M derived: sum of 2 quarters · filed 2024-05-08 | $12.61M derived: sum of 3 quarters · filed 2024-05-08 | $16.23M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $4.61M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-04 | $8.56M derived: sum of 2 quarters · filed 2024-03-04 | $12.18M derived: sum of 3 quarters · filed 2024-03-04 | $15.49M 10-K · filed 2024-03-04 |
| 2022-09-30 | $3.96M 10-Q · filed 2023-11-07 | $7.58M derived: sum of 2 quarters · filed 2023-11-07 | $10.89M 10-Q · filed 2023-11-07 | $13.95M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $3.62M 10-Q · filed 2023-08-08 | $6.93M 10-Q · filed 2023-08-08 | $10.00M derived: sum of 3 quarters · filed 2023-08-08 | $12.15M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $3.31M 10-Q · filed 2023-05-09 | $6.38M derived: sum of 2 quarters · filed 2023-05-09 | $8.53M derived: sum of 3 quarters · filed 2023-05-09 | $9.87M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $3.07M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $5.22M derived: sum of 2 quarters · filed 2023-03-06 | $6.55M derived: sum of 3 quarters · filed 2023-03-06 | $6.62M 10-K · filed 2023-03-06 |
| 2021-09-30 | $2.15M 10-Q · filed 2022-11-08 | $3.49M derived: sum of 2 quarters · filed 2022-11-08 | $3.55M 10-Q · filed 2022-11-08 | $3.89M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $1.33M 10-Q · filed 2022-08-09 | $1.40M 10-Q · filed 2022-08-09 | $1.73M derived: sum of 3 quarters · filed 2022-08-09 | $1.80M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $62.00K 10-Q · filed 2022-05-06 | $398.00K derived: sum of 2 quarters · filed 2022-05-06 | $470.00K derived: sum of 3 quarters · filed 2022-05-06 | $541.00K derived: sum of 4 quarters · filed 2022-05-06 |
| 2020-12-31 | $336.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $408.00K derived: sum of 2 quarters · filed 2022-03-01 | $479.00K derived: sum of 3 quarters · filed 2022-03-01 | $656.00K 10-K · filed 2022-03-01 |
| 2020-09-30 | $72.00K 10-Q · filed 2021-11-09 | $143.00K derived: sum of 2 quarters · filed 2021-11-09 | $320.00K 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $71.00K 10-Q · filed 2021-08-12 | $248.00K 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $177.00K 10-Q · filed 2021-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |